Alabama to launch medical cannabis program

After years of delays, lawsuits, and political deadlocks, the’Alabama has finally taken a decisive step toward making the medical marijuana for patients. On Thursday, the Alabama Medical Cannabis Commission (AMCC) approved the licenses for three clinics, a crucial step forward for a program that had been at a standstill since its inception in 2021.

According to the president of the AMCC, Rex Vaughn, this vote marked a turning point after months of procedural setbacks. «This is a decisive day for us. There’s no doubt about it. We’ve been waiting for this day for a long time,» he said, adding that the products could be made available to patients by spring 2026.

This decision also marks the first concrete step forward since the government authorized medical cannabis under the Compassion Act, a a law signed by Governor Kay Ivey four years ago. Since then, various obstacles have repeatedly delayed the issuance of licenses for cultivation, processing, and retail sales.

Health clinics are making progress despite ongoing legal challenges

The AMCC approved the companies deemed «most appropriate» by the administrative judge Blake Brookshire, which held detailed hearings on the competing candidates earlier this year. Its 106-page report recommended four companies— GP6 Wellness LLC, RJK Holdings LLC, CCS of Alabama LLC and Yellowhammer Medical Dispensaries LLC – as meeting the government's strict criteria.

Although the commission adopted the report, it temporarily suspended Yellowhammer’s license until January 26, at which time the AMCC may decide to finalize its approval. The other companies now have 14 days to pay their annual license fees of $40,000.

Each approved operator will be authorized to open three clinics, bringing the maximum number of sites to 12 for now. This number could increase significantly once the government has resolved the disputes concerning the integrated bachelor's degrees, a category that allows businesses to manage cultivation, processing, and distribution under a single license. Up to five integrated operators might finally open five retail locations each, which would bring the total to 37 statewide.

Despite this bottleneck, farmers who obtained a license during the first rounds have already begun to grow cannabis, and the AMCC states that the next step will be to certify physicians and launch the patient registry.

A long-awaited victory for patient advocates

For Amanda Taylor, a prominent patient advocate who once left Alabama to gain access to medical cannabis to treat her multiple sclerosis, this vote marks a long-awaited step forward. «I am absolutely thrilled today because we are on the verge of having a fully operational program,» she said.

Ms. Taylor is one of the most ardent advocates for access to medical cannabis. She has been closely following the commission’s work ever since she stood alongside Governor Ivey during the signing of the bill. Referring to the delays, she added, «It shouldn’t have taken this long. But I want to commend the commission for working tirelessly.»

Business leaders also expressed their relief. Vince Schilleci, co-owner of CCS Alabama, said the company had already prepared the equipment for its first site in Montgomery. «I’m so happy today,» he said. «For the patients, it’s been a long, long process. We hate that it’s been delayed, but we’re looking forward to getting started on January 8.»

What can patients expect when sales begin?

Once the clinics are open and doctors are authorized to recommend medical marijuana, patients with a certified card will be able to purchase products authorized under Alabama law. The Compassion Act limits product forms to gummies (peach-flavored only), capsules, and dyes, tablets, oils, patches, and other non-smokable forms.

Eligible conditions include, among others, chronic pain, cancer-related nausea or weight loss, post-traumatic stress disorder, epilepsy, panic disorders, and muscle spasms caused by disease or spinal cord injuries.